Literature DB >> 1629703

Failure to isolate human T cell lymphotropic virus type I and to detect variant-specific genomic sequences by polymerase chain reaction in Melanesians with indeterminate western immunoblot.

V R Nerurkar1, M A Miller, M E Leon-Monzon, A B Ajdukiewicz, C L Jenkins, R C Sanders, M S Godec, R M Garruto, R Yanagihara.   

Abstract

The controversy over the endemicity of human T cell lymphotropic virus type I (HTLV-I) in Melanesia has been settled recently by the isolation of genetically distinct, highly divergent sequence variants of HTLV-I from unrelated inhabitants of Papua New Guinea and the Solomon Islands. Still at issue, however, is the significance of the high frequency of indeterminate HTLV-I Western blots (defined as reactivity to only gag-encoded proteins) among Melanesians. To investigate whether this indeterminate seroreactivity reflects specific reactivity to the Melanesian HTLV-I variants, 27 seroindeterminate Melanesians from Papua New Guinea and the Solomon Islands were studied for evidence of HTLV-I infection. Although antibodies against Melanesian variant-specific env gene products and variant-specific env gene sequences were detected by Western blot analysis and polymerase chain reaction, respectively, in all 11 HTLV-I Western blot-positive Melanesians, none of the 27 seroindeterminate Melanesians had such variant-specific antibodies or HTLV-I proviral sequences. In addition, attempts to isolate HTLV-I from seroindeterminate individuals were unsuccessful. These data indicate that HTLV-I infection is not the cause of the indeterminate Western blot reactivity seen in Melanesia.

Entities:  

Mesh:

Year:  1992        PMID: 1629703     DOI: 10.1099/0022-1317-73-7-1805

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

1.  Seroprevalence of anti-HTLV I/II and anti-HIV-1 antibodies in a sample population in the Marche Region, Italy.

Authors:  F Mignini; L Quarenghi; S Cipriani; M Bartolucci; I Covelli
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

2.  Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection.

Authors:  R Mahieux; P Horal; P Mauclère; O Mercereau-Puijalon; M Guillotte; L Meertens; E Murphy; A Gessain
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

3.  Serological, epidemiological, and molecular differences between human T-cell lymphotropic virus Type 1 (HTLV-1)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from the Caribbean.

Authors:  F Rouet; L Meertens; G Courouble; C Herrmann-Storck; R Pabingui; B Chancerel; A Abid; M Strobel; P Mauclere; A Gessain
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

4.  Genetic and phylogenetic analyses of human T-cell lymphotropic virus type I variants from Melanesians with and without spastic myelopathy.

Authors:  V R Nerurkar; K J Song; R R Melland; R Yanagihara
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

5.  Antenatal survey for the seroprevalence of HTLV-1 infections in the West Midlands, England.

Authors:  S Nightingale; D Orton; D Ratcliffe; S Skidmore; J Tosswill; U Desselberger
Journal:  Epidemiol Infect       Date:  1993-04       Impact factor: 2.451

6.  Immunologic cross-reactivity between structural proteins of human T-cell lymphotropic virus type I and the blood stage of Plasmodium falciparum.

Authors:  R B Lal; D Rudolph; M P Alpers; A J Sulzer; Y P Shi; A A Lal
Journal:  Clin Diagn Lab Immunol       Date:  1994-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.